# FDA Inspection 1213062 - Rahul M. Ladwa, M.D. - July 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/rahul-m-ladwa-md/c9725dc9-83d6-474b-ac29-9aa345a05adb
Source feed: FDA_Inspections

> FDA Inspection 1213062 for Rahul M. Ladwa, M.D. on July 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1213062
- Company Name: Rahul M. Ladwa, M.D.
- Inspection Date: 2023-07-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/rahul-m-ladwa-md/9f605fc9-7ef4-439a-b77c-ede6a0833f78

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c